James L Ferrara, MD
img_James L Ferrara
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Pediatrics
PROFESSOR | Oncological Sciences
PROFESSOR | Immunology & Immunotherapy
Research Topics
Cytokines, Immunological Tolerance, Immunology, Inflammation, Stem Cells, Transplantation
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]
Publications

Selected Publications

Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis Ayuk, Hannah Choe, William Hogan, Zachariah DeFilipp, Muna Qayed, Aaron M. Etra, Karam Sandhu, Sabrina Kraus, Tim Olson, Elizabeth Hexner, Paibel Aguayo-Hiraldo, Ran Reshef, Evelyn Ullrich, Tal Schechter, Carrie Kitko, Chantiya Chanswangphuwana, Pietro Merli, Yu Akahoshi, Janna Baez, Gilbert Eng, Rahnuma Beheshti, Steven Kowalyk, George Morales, Ioannis Evangelos Louloudis, Rachel Young, Ernst Holler, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine. Transplantation and Cellular Therapy

1<sub>8</sub> F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Jennifer Holter-Chakrabarty, Lacey McNally, John Levine, James Ferrara, Sara K. Vesely, Christopher G. Kanakry, Tabitha Garwe, Zheng Han, Manu Pandey, Joshua Glover, Yuejin Wen, Ron Gress, Kirsten M. Williams. Radiology: Imaging Cancer

Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease. Daniela Guisado, Sayali Talware, Xiaoli Wang, Andrew Davis, Elbek Fozilov, Aaron Etra, Jean Frederic Colombel, Christoph Schaniel, Christopher Tastad, John E. Levine, James L.M. Ferrara, Chuang Ling-Shiang, Ksenija Sabic, Shishir Singh, Bridget K. Marcellino, Ronald Hoffman, Judy Cho, Louis Cohen. Gut

View All Publications

Precision BMT Through Biomarkers

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ferrara has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.